First Horizon Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.33M | Sell |
10,673
-97
| -0.9% | -$40.6K | 0.11% | 157 |
|
|
2025
Q1 | $5.36M | Sell |
10,770
-406
| -4% | -$220K | 0.15% | 139 |
|
|
2024
Q4 | $5.81M | Sell |
11,176
-597
| -5% | -$328K | 0.16% | 134 |
|
|
2024
Q3 | $7.28M | Sell |
11,773
-421
| -3% | -$249K | 0.2% | 127 |
|
|
2024
Q2 | $6.74M | Sell |
12,194
-979
| -7% | -$561K | 0.21% | 129 |
|
|
2024
Q1 | $7.66M | Sell |
13,173
-167
| -1% | -$93.7K | 0.24% | 122 |
|
|
2023
Q4 | $7.08M | Sell |
13,340
-2,984
| -18% | -$1.44M | 0.23% | 124 |
|
|
2023
Q3 | $8.26M | Buy |
16,324
+376
| +2% | +$200K | 0.3% | 106 |
|
|
2023
Q2 | $8.32M | Sell |
15,948
-407
| -2% | -$220K | 0.29% | 107 |
|
|
2023
Q1 | $9.43M | Sell |
16,355
-781
| -5% | -$440K | 0.34% | 92 |
|
|
2022
Q4 | $9.44M | Sell |
17,136
-1,532
| -8% | -$812K | 0.35% | 88 |
|
|
2022
Q3 | $9.47M | Sell |
18,668
-2,406
| -11% | -$1.35M | 0.38% | 84 |
|
|
2022
Q2 | $11.4M | Sell |
21,074
-4,789
| -19% | -$2.64M | 0.41% | 77 |
|
|
2022
Q1 | $15.3M | Sell |
25,863
-5,124
| -17% | -$2.94M | 0.84% | 26 |
|
|
2021
Q4 | $20.7M | Sell |
30,987
-448
| -1% | -$280K | 0.62% | 45 |
|
|
2021
Q3 | $18M | Buy |
31,435
+28,011
| +818% | +$15.4M | 0.59% | 47 |
|
|
2021
Q2 | $1.73M | Buy |
3,424
+21
| +0.6% | +$9.91K | 0.09% | 166 |
|
|
2021
Q1 | $1.55M | Buy |
3,403
+31
| +0.9% | +$14.8K | 0.09% | 164 |
|
|
2020
Q4 | $1.57M | Sell |
3,372
-206
| -6% | -$96.6K | 0.11% | 146 |
|
|
2020
Q3 | $1.58M | Sell |
3,578
-159
| -4% | -$65.7K | 0.12% | 139 |
|
|
2020
Q2 | $1.35M | Sell |
3,737
-108
| -3% | -$36.2K | 0.11% | 147 |
|
|
2020
Q1 | $1.09M | Sell |
3,845
-105
| -3% | -$33.1K | 0.1% | 147 |
|
|
2019
Q4 | $1.28M | Sell |
3,950
-28
| -0.7% | -$8.49K | 0.09% | 159 |
|
|
2019
Q3 | $1.16M | Sell |
3,978
-503
| -11% | -$144K | 0.09% | 159 |
|
|
2019
Q2 | $1.31M | Sell |
4,481
-570
| -11% | -$157K | 0.1% | 157 |
|
|
2019
Q1 | $1.38M | Sell |
5,051
-172
| -3% | -$42.8K | 0.11% | 151 |
|
|
2018
Q4 | $1.17M | Sell |
5,223
-2,494
| -32% | -$585K | 0.1% | 157 |
|
|
2018
Q3 | $1.88M | Sell |
7,717
-321
| -4% | -$73.8K | 0.15% | 143 |
|
|
2018
Q2 | $1.66M | Buy |
8,038
+3,079
| +62% | +$654K | 0.14% | 146 |
|
|
2018
Q1 | $1.03M | Sell |
4,959
-196
| -4% | -$41.1K | 0.1% | 155 |
|
|
2017
Q4 | $992K | Buy |
5,155
+384
| +8% | +$73.6K | 0.09% | 164 |
|
|
2017
Q3 | $904K | Sell |
4,771
-39
| -0.8% | -$7.06K | 0.09% | 163 |
|
|
2017
Q2 | $838K | Sell |
4,810
-17,603
| -79% | -$2.96M | 0.09% | 158 |
|
|
2017
Q1 | $3.45M | Sell |
22,413
-15,513
| -41% | -$2.37M | 0.39% | 81 |
|
|
2016
Q4 | $5.99M | Hold |
37,926
| – | – | 0.76% | 37 |
|
|
2016
Q3 | $5.99M | Buy |
37,926
+74
| +0.2% | +$11.4K | 0.76% | 37 |
|
|
2016
Q2 | $5.59M | Sell |
37,852
-5,497
| -13% | -$811K | 0.76% | 37 |
|
|
2016
Q1 | $6.19M | Buy |
43,349
+3,560
| +9% | +$477K | 0.69% | 44 |
|
|
2015
Q4 | $5.64M | Sell |
39,789
-1,201
| -3% | -$160K | 1% | 21 |
|
|
2015
Q3 | $5.01M | Buy |
40,990
+307
| +0.8% | +$40K | 0.77% | 42 |
|
|
2015
Q2 | $5.28M | Buy |
40,683
+906
| +2% | +$118K | 0.77% | 39 |
|
|
2015
Q1 | $5.35M | Buy |
39,777
+1,580
| +4% | +$204K | 0.77% | 36 |
|
|
2014
Q4 | $4.79M | Buy |
38,197
+1,791
| +5% | +$218K | 0.74% | 36 |
|
|
2014
Q3 | $4.43M | Buy |
36,406
+434
| +1% | +$52.8K | 0.69% | 36 |
|
|
2014
Q2 | $4.25M | Buy |
35,972
+1,500
| +4% | +$177K | 0.62% | 40 |
|
|
2014
Q1 | $4.14M | Sell |
34,472
-1,350
| -4% | -$161K | 0.58% | 33 |
|
|
2013
Q4 | $3.85M | Buy |
35,822
+339
| +1% | +$33.7K | 0.58% | 34 |
|
|
2013
Q3 | $3.27M | Buy |
35,483
+33,069
| +1,370% | +$2.99M | 0.53% | 43 |
|
|
2013
Q2 | $204K | Buy |
+2,414
| New | +$201K | 0.1% | 70 |
|
Other funds holding TMO
First Horizon Advisors's TMO Position: Q2 2025 in Review
First Horizon Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.9% in Q2 2025, selling an estimated $40.6K and leaving 10,673 shares worth $4.33M. The position accounts for 0.11% of the portfolio, ranked #157.
First Horizon Advisors first reported a position in TMO in Q2 2013 and has held it in 49 quarters since. The position peaked at $20.7M in Q4 2021. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.
- First Horizon Advisors held 10,673 shares of Thermo Fisher Scientific worth $4.33M as of Q2 2025.
- First Horizon Advisors sold 97 Thermo Fisher Scientific shares in Q2 2025, an estimated $40.6K.
- Thermo Fisher Scientific made up 0.11% of First Horizon Advisors's portfolio in Q2 2025, its #157 holding.
- First Horizon Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's Thermo Fisher Scientific position peaked at $20.7M in Q4 2021.
- 2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.